30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The nucleolus is the major site for synthesis of ribosomes, complex molecular machines that are responsible for protein synthesis. A wealth of research over the past 20 years has clearly indicated that both quantitative and qualitative alterations in ribosome biogenesis can drive the malignant phenotype via dysregulation of protein synthesis. However, numerous recent proteomic, genomic, and functional studies have implicated the nucleolus in the regulation of processes that are unrelated to ribosome biogenesis, including DNA-damage response, maintenance of genome stability and its spatial organization, epigenetic regulation, cell-cycle control, stress responses, senescence, global gene expression, as well as assembly or maturation of various ribonucleoprotein particles. In this review, the focus will be on features of rDNA genes, which make them highly vulnerable to DNA damage and intra- and interchromosomal recombination as well as built-in mechanisms that prevent and repair rDNA damage, and how dysregulation of this interplay affects genome-wide DNA stability, gene expression and the balance between euchromatin and heterochromatin. We will also present the most recent insights into how malfunction of these cellular processes may be a central driving force of human malignancies, and propose a promising new therapeutic approach for the treatment of cancer.

          Related collections

          Most cited references118

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

          Many different types of cancer show a high incidence of TP53 mutations, leading to the expression of mutant p53 proteins. There is growing evidence that these mutant p53s have both lost wild-type p53 tumor suppressor activity and gained functions that help to contribute to malignant progression. Understanding the functions of mutant p53 will help in the development of new therapeutic approaches that may be useful in a broad range of cancer types.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            ATM and related protein kinases: safeguarding genome integrity.

            Maintenance of genome stability is essential for avoiding the passage to neoplasia. The DNA-damage response--a cornerstone of genome stability--occurs by a swift transduction of the DNA-damage signal to many cellular pathways. A prime example is the cellular response to DNA double-strand breaks, which activate the ATM protein kinase that, in turn, modulates numerous signalling pathways. ATM mutations lead to the cancer-predisposing genetic disorder ataxia-telangiectasia (A-T). Understanding ATM's mode of action provides new insights into the association between defective responses to DNA damage and cancer, and brings us closer to resolving the issue of cancer predisposition in some A-T carriers.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The Nucleolus under Stress

              Cells typically respond quickly to stress, altering their metabolism to compensate. In mammalian cells, stress signaling usually leads to either cell-cycle arrest or apoptosis, depending on the severity of the insult and the ability of the cell to recover. Stress also often leads to reorganization of nuclear architecture, reflecting the simultaneous inhibition of major nuclear pathways (e.g., replication and transcription) and activation of specific stress responses (e.g., DNA repair). In this review, we focus on how two nuclear organelles, the nucleolus and the Cajal body, respond to stress. The nucleolus senses stress and is a central hub for coordinating the stress response. We review nucleolar function in the stress-induced regulation of p53 and the specific changes in nucleolar morphology and composition that occur upon stress. Crosstalk between nucleoli and CBs is also discussed in the context of stress responses.
                Bookmark

                Author and article information

                Contributors
                +(45) 35 25 73 57 , jb@cancer.dk
                +(385) 51 651 120 , sinisa.volarevic@medri.uniri.hr
                Journal
                Oncogene
                Oncogene
                Oncogene
                Nature Publishing Group UK (London )
                0950-9232
                1476-5594
                12 February 2018
                12 February 2018
                2018
                : 37
                : 18
                : 2351-2366
                Affiliations
                [1 ]ISNI 0000 0004 1937 0626, GRID grid.4714.6, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, , Karolinska Institutet, ; Stockholm, Sweden
                [2 ]ISNI 0000 0001 2236 1630, GRID grid.22939.33, Department of Molecular Medicine and Biotechnology, School of Medicine, , University of Rijeka, ; Rijeka, Croatia
                [3 ]ISNI 0000 0001 2236 1630, GRID grid.22939.33, Scientific Center of Excellence for Reproductive and Regenerative Medicine, , University of Rijeka, ; Rijeka, Croatia
                [4 ]ISNI 0000 0001 2175 6024, GRID grid.417390.8, The Danish Cancer Society Research Centre, ; Copenhagen, Denmark
                Article
                121
                10.1038/s41388-017-0121-z
                5931986
                29429989
                1a64cb18-8180-4821-906a-7bd4add34c2b
                © The Author(s) 2018

                Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

                History
                : 10 October 2017
                : 15 November 2017
                : 15 November 2017
                Categories
                Review Article
                Custom metadata
                © Macmillan Publishers Limited, part of Springer Nature 2018

                Oncology & Radiotherapy
                Oncology & Radiotherapy

                Comments

                Comment on this article